Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM12034) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
DUS1L
|
||||||
Official Full Name |
Dihydrouridine Synthase 1 Like
|
||||||
Synonym |
Dihydrouridine Synthase 1 Like;PP3111;DUS1;TRNA-Dihydrouridine(16/17) Synthase [NAD(P)(+)]-Like;Dihydrouridine Synthase 1-Like (S. Cerevisiae);TRNA-Dihydrouridine Synthase 1-Like;EC 1.3.1
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr17(Start:82057506 - End:82065887)
|
||||||
Strand |
-
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
2C30: Melanoma of skin | Cutaneous Melanoma [Melanoma of skin] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
LD2C: Overgrowth syndromes | Sotos syndrome(SS) [Overgrowth syndromes] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH4XG8: Chronic myeloid leukaemia | Chronic Phase-Chronic Myeloid Leukemia [Chronic myeloid leukaemia] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Valerate has been shown to hypermethylate DUS1L CpG site in breast cancer cells.
|
||||||
Metabolite Name: Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Valerate has been shown to hypomethylateDUS1L CpG site in breast cancer cells.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.